eXoZymes, Inc. (EXOZ) vs MiNK Therapeutics, Inc. (INKT)

A side-by-side comparison of eXoZymes, Inc. and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
eXoZymes, Inc. logo
EXOZ
eXoZymes, Inc.
$53M
$5.72HealthcareDelayed quote: Oct 6, 2026, 10:42 AM EDT
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
$61M
$12.15HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT

Total return — EXOZ vs INKT

growth of $100 · dividends reinvested · last 2y
EXOZ -36.2% (-20.1%/yr)INKT +53.7% (+24.0%/yr)INKT compounded faster over this window
0200400600800Start $10020252026$64$154
EXOZ INKT

EXOZ vs INKT: by the numbers

  • •INKT is the larger company ($61M vs $53M market cap).

Metrics side by side

Valuation

MetricEXOZINKT
P/B ratio14.53N/A

Profitability

MetricEXOZINKT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-278.89%N/A
ROIC-157.40%-604.20%

Go deeper

Full EXOZ analysisFull INKT analysisInteractive comparison tool

Dig into the metrics

eXoZymes ROEMiNK Therapeutics ROEeXoZymes operating marginMiNK Therapeutics operating margineXoZymes revenue growthMiNK Therapeutics revenue growtheXoZymes free cash flowMiNK Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.